BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2297011)

  • 1. Botulism: north to Alaska.
    Lancaster MJ
    Am J Nurs; 1990 Jan; 90(1):60-2. PubMed ID: 2297011
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pathogenesis of botulism].
    Rosin H
    Tierarztl Prax; 1973; 1(2):241-43. PubMed ID: 4618931
    [No Abstract]   [Full Text] [Related]  

  • 3. Botulism and its control.
    Taylor A
    Am J Nurs; 1973 Aug; 73(8):1380-2. PubMed ID: 4489758
    [No Abstract]   [Full Text] [Related]  

  • 4. Human botulism caused by Clostridium botulinum type E: the Birmingham outbreak.
    Ball AP; Hopkinson RB; Farrell ID; Hutchison JG; Paul R; Watson RD; Page AJ; Parker RG; Edwards CW; Snow M; Scott DK; Leone-Ganado A; Hastings A; Ghosh AC; Gilbert RJ
    Q J Med; 1979 Jul; 48(191):473-91. PubMed ID: 575566
    [No Abstract]   [Full Text] [Related]  

  • 5. [Quick recovery, after administration of a botulinic antitoxin serum in two patients presenting with botulism].
    Oswald L; Lefebvre N; Camuset G; Gourieux B; Lutun P; Schramm F; Hansmann Y; Christmann D
    Med Mal Infect; 2011 Jan; 41(1):44-6. PubMed ID: 21094008
    [No Abstract]   [Full Text] [Related]  

  • 6. Persistence of botulinum toxin in patients' serum: Alaska, 1959-2007.
    Fagan RP; McLaughlin JB; Middaugh JP
    J Infect Dis; 2009 Apr; 199(7):1029-31. PubMed ID: 19203262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Familial occurrence of botulism - a case report].
    AmbroŽová H; DŽupová O; Smíšková D; Roháčová H
    Klin Mikrobiol Infekc Lek; 2014 Jun; 20(2):40-2. PubMed ID: 25135138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Serotherapy of botulism].
    Nikiforov VN; Glukhikh OA; Nikiforov VV; Rezepov FF; Akhizova TIa
    Sov Med; 1986; (9):44-7. PubMed ID: 3798222
    [No Abstract]   [Full Text] [Related]  

  • 9. [Familial botulism epidemic].
    Sandman F
    Tierarztl Prax; 1973; 1(2):237-9. PubMed ID: 4618930
    [No Abstract]   [Full Text] [Related]  

  • 10. Botulism in China.
    Shih Y; Chao SY
    Rev Infect Dis; 1986; 8(6):984-90. PubMed ID: 3797939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Specific antitoxic therapy of botulism].
    Nikiforov VN; Nikiforov VV; Glukhikh OA; Tashpulatov ShA
    Sov Med; 1985; (10):46-50. PubMed ID: 3909448
    [No Abstract]   [Full Text] [Related]  

  • 12. Botulism revisited. A case report.
    Hakala M; Apajalahti J; Jounela AJ; Kallanranta T; Lilja M
    Schweiz Med Wochenschr; 1984 Jan; 114(1):7-9. PubMed ID: 6695165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical botulism sparing palsy of extraocular muscles.
    Gdynia HJ; Huber R; Kastrup A; Riecker A
    Eur J Med Res; 2007 Jul; 12(7):300-1. PubMed ID: 17933702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigational heptavalent botulinum antitoxin (HBAT) to replace licensed botulinum antitoxin AB and investigational botulinum antitoxin E.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 Mar; 59(10):299. PubMed ID: 20300057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulism.
    Sobel J
    Clin Infect Dis; 2005 Oct; 41(8):1167-73. PubMed ID: 16163636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initial recovery and rebound of type f intestinal colonization botulism after administration of investigational heptavalent botulinum antitoxin.
    Fagan RP; Neil KP; Sasich R; Luquez C; Asaad H; Maslanka S; Khalil W
    Clin Infect Dis; 2011 Nov; 53(9):e125-8. PubMed ID: 21896700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnostic difficulties in foodborne botulism--case reports and literature review].
    Chwaluk P; Chwaluk A
    Przegl Lek; 2007; 64(4-5):348-51. PubMed ID: 17724910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of botulism in a resuscitation unit. 4 years of experience at the Centre Anti-Poisons of Marseilles].
    Jouglard J; Airaudo CB; Sainty JM; Grigorian G; Ohresser P
    Sem Hop; 1972 Dec; 48(51):3405-10. PubMed ID: 4347500
    [No Abstract]   [Full Text] [Related]  

  • 19. Equine antitoxin use and other factors that predict outcome in type A foodborne botulism.
    Tacket CO; Shandera WX; Mann JM; Hargrett NT; Blake PA
    Am J Med; 1984 May; 76(5):794-8. PubMed ID: 6720725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitoxin levels in botulism patients treated with trivalent equine botulism antitoxin to toxin types A, B, and E.
    Hatheway CH; Snyder JD; Seals JE; Edell TA; Lewis GE
    J Infect Dis; 1984 Sep; 150(3):407-12. PubMed ID: 6481185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.